Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more
Microbix Biosystems Inc. (MBXBF) - Total Assets
Latest total assets as of September 2025: $37.41 Million USD
Based on the latest financial reports, Microbix Biosystems Inc. (MBXBF) holds total assets worth $37.41 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Microbix Biosystems Inc. - Total Assets Trend (2000–2025)
This chart illustrates how Microbix Biosystems Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Microbix Biosystems Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Microbix Biosystems Inc.'s total assets of $37.41 Million consist of 63.0% current assets and 37.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.4% |
| Accounts Receivable | $1.61 Million | 4.3% |
| Inventory | $9.20 Million | 24.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.73 Million | 10.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Microbix Biosystems Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Microbix Biosystems Inc.'s current assets represent 63.0% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 32.4% of total assets in 2025, up from 19.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 24.6% of total assets.
Microbix Biosystems Inc. Competitors by Total Assets
Key competitors of Microbix Biosystems Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Microbix Biosystems Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Microbix Biosystems Inc. generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Microbix Biosystems Inc. is currently not profitable relative to its asset base.
Microbix Biosystems Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.48 | 7.15 | 1.62 |
| Quick Ratio | 5.17 | 5.24 | 0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $20.80 Million | $ 20.87 Million | $ 2.74 Million |
Microbix Biosystems Inc. - Advanced Valuation Insights
This section examines the relationship between Microbix Biosystems Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.07 |
| Latest Market Cap to Assets Ratio | 0.63 |
| Asset Growth Rate (YoY) | -1.8% |
| Total Assets | $37.41 Million |
| Market Capitalization | $23.67 Million USD |
Valuation Analysis
Below Book Valuation: The market values Microbix Biosystems Inc.'s assets below their book value (0.63 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Microbix Biosystems Inc.'s assets decreased by 1.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Microbix Biosystems Inc. (2000–2025)
The table below shows the annual total assets of Microbix Biosystems Inc. from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $37.41 Million | -1.80% |
| 2024-09-30 | $38.10 Million | +6.85% |
| 2023-09-30 | $35.65 Million | +7.57% |
| 2022-09-30 | $33.15 Million | +14.97% |
| 2021-09-30 | $28.83 Million | +84.83% |
| 2020-09-30 | $15.60 Million | -20.54% |
| 2019-09-30 | $19.63 Million | +1.65% |
| 2018-09-30 | $19.31 Million | -26.96% |
| 2017-09-30 | $26.44 Million | +4.71% |
| 2016-09-30 | $25.25 Million | +7.22% |
| 2015-09-30 | $23.55 Million | +46.51% |
| 2014-09-30 | $16.07 Million | +30.31% |
| 2013-09-30 | $12.33 Million | -10.32% |
| 2012-09-30 | $13.75 Million | +4.56% |
| 2011-09-30 | $13.15 Million | -5.43% |
| 2010-09-30 | $13.91 Million | +5.54% |
| 2009-09-30 | $13.18 Million | -3.95% |
| 2008-09-30 | $13.72 Million | +134.45% |
| 2007-09-30 | $5.85 Million | +64.99% |
| 2006-09-30 | $3.55 Million | +4.45% |
| 2005-09-30 | $3.40 Million | +26.98% |
| 2004-09-30 | $2.67 Million | +21.48% |
| 2003-09-30 | $2.20 Million | +28.38% |
| 2002-09-30 | $1.71 Million | -8.86% |
| 2001-09-30 | $1.88 Million | -2.27% |
| 2000-09-30 | $1.93 Million | -- |